Rothman Institute Orthopaedics
rothmanortho.comTotal trials
116
Active
8
Phase 3
16
Total enrollment
20,306
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dexamethasone | — | — | — | — | 4 | ||
| OxyCODONE 5 mg Oral | — | — | — | — | 3 | ||
| Naproxen 500 Mg | — | — | — | — | 3 | ||
| Ketorolac | — | — | — | — | — | 2 | |
| Bupivacaine Hcl 0.5% Inj | — | — | — | — | — | 1 | |
| Exparel 266 MG Per 20 ML | — | — | — | — | — | 1 | |
| Bupivacaine Hcl 0.75% Inj | — | — | — | — | — | 1 | |
| Exparel 30 mL | — | — | — | — | — | 1 | |
| 0.5% bupivacaine | — | — | — | — | — | 1 | |
| iPACK block | — | — | — | — | — | 1 | |
| sterile saline solution | — | — | — | — | — | 1 | |
| Surgiphor | — | — | — | — | — | 1 | |
| Metaxalone 800 MG | — | — | — | — | — | 1 | |
| Liposomal bupivacaine | — | — | — | 3 |
Next readouts
- 2024-10-30
- 2025-06-30
- 2025-06-30
- 2025-08-30
- 2025-09-30
Top conditions
- Pain, Postoperative10
- Osteoarthritis5
- Postoperative Pain5
- Total Joint Arthroplasty4
- Rotator Cuff Tears4
- Osteo Arthritis Knee3
- Osteoarthritis of the Hip3
- Total Knee Replacement3
Frequently asked questions about Rothman Institute Orthopaedics
- How many clinical trials does Rothman Institute Orthopaedics have on ClinicalTrials.gov?
- Rothman Institute Orthopaedics is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Rothman Institute Orthopaedics's trials are in Phase 3?
- 16 of Rothman Institute Orthopaedics's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Rothman Institute Orthopaedics focus on?
- Rothman Institute Orthopaedics's most-studied conditions on ClinicalTrials.gov are Pain, Postoperative, Osteoarthritis, Postoperative Pain, Total Joint Arthroplasty, Rotator Cuff Tears.
- When are Rothman Institute Orthopaedics's next clinical trial readouts?
- Rothman Institute Orthopaedics has 5 upcoming primary-completion readouts tracked here; the soonest is “Exparel vs Block for ACL Reconstruction”, expected around 2024-10-30.